NRF 2022
The convenience of online shopping means those crowded malls are no longer. No more waiting in a long line to purchase an item, no more pushing through crowds. But also, no longer being able to see the item in a room, on display. No more walking into a store and seeing the products incorporated…
Latest
NRF 2022
Why Virtual Dressing Rooms Will Be Key for Differentiating in Retail
The days of retail clothiers needing to stock multiple garment sizes could be drawing to a close. NOBAL Technologies developed a product poised to revolutionize the customer retail experience with its interactive iMirror solution. Daniel Maher, VP of Technology at NOBAL, joined Retail Refined’s Melissa Gonzalez at NRF to talk about the positive impact iMirror…
NRF 2022
How Fast Fashion Can Fix Its Sustainability Reputation Through the Supply Chain
While at the world’s largest retail conference and expo, Retail Refined Host Melissa Gonzalez spoke with Chris Georgen, Founder and Chief Architect of Topl, a company that sits at the intersection of sustainability, deep-technology, and innovation. Topl, whose mission is to build trust between consumers and products, is set largely within an industry which…
NRF 2022
Bringing One-click Checkouts to Merchants of All Sizes
Ian Leslie, Senior Director of Retail Advocacy at Bolt, joined Retail Refined for a live chat at NRF 2020. Bolt is a San Francisco-based one-click checkout solution powering checkout across e-commerce merchants across the internet. “We’re trying to bring one-click checkout to all merchants whether they’re big or small,” Leslie said. “Give them a best-in-class…
NRF 2022
How Will A Decrease in Foot Traffic Impact the In-Store Environment?
What is the social and economic impact of declining foot traffic at malls around the country? To get insight into this question the Host of Retail Refined, Melissa Gonzalez, sat down with Karen Bomber, the Vice President of Global Marketing for Honeywell, at NRF 2022 to discuss the direct correlation between foot traffic and the…
NRF 2022
Pop-Up Retailers Will Finally Have Analytics to Chart Success
This episode of Retail Refined explored the emerging spatial intelligence technology that provides pop-up stores the opportunity to utilize real-time analytics to enhance the buying and selling experience. George Shaw, founder of Pathr.ai, and Melissa Gonzalez of The Lionesque Group discussed the technology that is set to transform retail environments throughout the world. “We’ve…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
